Bromide

Bromide

SCHEMBL4288724

CCCCCCCCCCCCCCCCN(C(=O)CCCCCCCCC[N+](C)(C)C)[C@@](CCCCCCCCCCCCCCCC)(CCC(=O)O)C(=O)O.[Br-]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 6/20 0.40
KDM4C Q9H3R0 6/20 0.40
PHF8 Q9UPP1 4/20 0.40
EPHX2 P34913 3/20 0.38
KDM5C P41229 1/20 0.38
KDM5B Q9UGL1 1/20 0.38
DNM1 Q05193 2/20 0.37
KDM4A O75164 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37
FFAR1 O14842 1/20 0.37
PPARG P37231 3/20 0.36
PPARD Q03181 3/20 0.36
PPARA Q07869 3/20 0.36
TSHR P16473 2/20 0.36
GPR84 Q9NQS5 2/20 0.36
HDAC11 Q96DB2 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
ALDH1A1 P00352 1/20 0.36
SLC22A6 Q4U2R8 1/20 0.36
SLC22A8 Q8TCC7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL4299773 1.00 KDM5A (0.40) KDM5AKDM4CPHF8EPHX2KDM5C
SCHEMBL8526562 0.90 KDM5A (0.47) KDM5AKDM4CPHF8EPHX2KDM5C
SCHEMBL690298 0.90 KDM5A (0.47) KDM5AKDM4CPHF8EPHX2KDM5C
SCHEMBL29280736 0.90 KDM5A (0.47) KDM5AKDM4CPHF8EPHX2KDM5C
SCHEMBL690693 0.90 KDM5A (0.47) KDM5AKDM4CPHF8EPHX2KDM5C
SCHEMBL29403129 0.90 KDM5A (0.47) KDM5AKDM4CPHF8EPHX2KDM5C
SCHEMBL4334125 0.85 KDM5A (0.37) KDM5AKDM4CPHF8EPHX2FFAR4
SCHEMBL4325880 0.85 KDM5A (0.37) KDM5AKDM4CPHF8EPHX2FFAR4
SCHEMBL21048580 0.85 KDM5A (0.37) KDM5AKDM4CPHF8EPHX2FFAR4
SCHEMBL2192540 0.85 KDM5A (0.47) KDM5AKDM4CPHF8FFAR4FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2034019-B1 COMPOSITION FOR NUCLEIC-ACID INTRODUCTION HOKKAIDO SYSTEM SCIENCE CO LTD (JP) 2014-08-20 EP disclosed
US-8227248-B2 Composition for nucleic-acid transfection HOKKAIDO SYSTEM SCIENCE CO., LTD. (JP) 2012-07-24 US disclosed
US-20090239222-A1 COMPOSITION FOR NUCLEIC-ACID TRANSFECTION HOKKAIDO SYSTEM SCIENCE CO., LTD. (JP) 2009-09-24 US disclosed
EP-2034019-A1 COMPOSITION FOR NUCLEIC-ACID INTRODUCTION Hokkaido System Science Co., Ltd. (JP) 2009-03-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239222-A1 COMPOSITION FOR NUCLEIC-ACID TRANSFECTION HNRNPH3, RNASEH1, NSUN3 KDM5A 4776/4885KDM4C 4396/4885PHF8 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.